Nuevolution Sitemap Nuevolution
 
November 2, 2009
Nuevolution Announces Receipt of Milestone Payment from Merck & Co., Inc.
 
 
August 31,, 2009
Nuevolution Announces Research Collaboration with Novartis AG
 
 

July 28, 2009

Nuevolution Announces Worldwide Technology Cross-Licensing Agreement with GSK



Chemetics
® - A Quantum Leap for Small Molecule Lead Discovery

Nuevolution A/S is a company dedicated revolutionize fragment and HTS based lead discovery by applying its proprietary Chemetics® technologies enabling unprecedented synthesis and screening power for rapid and cost-efficient identification of drug leads.

Chemetics® represents the ultimate “convergent” drug discovery technology – a unique, patent protected fusion of proven wet chemistry and molecular biology methods producing an unrivaled capacity for synthesis and screening of millions to billions of drug-like molecules in a single test tube.


Discover ChemeticsDiscover Nuevolution
Home Sitemap Nuevolution info@nuevolution.com